Advertisement
Advertisement
Dr. Axe Wire · Food, herbs & supplements · nutrition
Plant Compound Shields Mouse Liver Cells From Alcohol Damage
A compound from a traditional Chinese herb reversed several alcohol-related liver injury pathways in mice and liver cells.
At a glance
- What they found: A compound isolated from the root of Paris polyphylla eased multiple forms of alcohol-related liver damage in mice and liver cells.
- Who was studied: In mice and ethanol-exposed liver cells.
- What it doesn't show: Whether it works the same way in people.
A compound isolated from the root of Paris polyphylla eased multiple forms of alcohol-related liver damage in mice and liver cells, according to a study published October 30, 2026 in Phytotherapy Research.
Researchers isolated polyphyllin I, a bioactive compound from the root of Paris polyphylla, a plant used in traditional Chinese medicine, and tested it in ethanol-exposed liver cells and a mouse model of alcoholic liver disease. A lab technique called a cellular thermal shift assay confirmed the compound physically engages a protein called PDE6D inside cells. Blocking PDE6D genetically worsened ethanol-induced ferroptosis, a form of iron-dependent cell death, by lowering levels of a signaling molecule called cGMP. A separate drug designed to degrade PDE6D reproduced the liver-protective effects seen with polyphyllin I, supporting the proposed mechanism.
Sample size was not reported in the available record.
Advertisement
The authors report that polyphyllin I raises cGMP levels and activates a downstream signaling protein called PKG, which then restores two proteins that guard against ferroptosis (xCT and GPX4), reduces a type of fat breakdown that damages cell membranes, boosts the cell's own antioxidant defense system, restores the cell's garbage-disposal process for clearing fat droplets, and calms an inflammation-driving signaling pathway called NF-κB. When the researchers blocked PKG with a drug, all four of these protective effects disappeared, which the authors say confirms the effects depend on that signaling pathway. Alcoholic liver disease typically involves oxidative damage, fat accumulation, cell death and inflammation occurring together, which is why a single-target drug often falls short; this compound worked on multiple fronts simultaneously in this model.
These findings establish PDE6D as a druggable vulnerability in ALD and suggest that PPI simultaneously suppresses ferroptosis and reprograms metabolic and immune homeostasis
This is early animal and cell-culture work with no human testing, and the paper does not report the number of mice or cells used. Dose, duration and whether the compound is safe or effective in people have not been established; human trials are the needed next step.
Dr. Axe’s Take
This pattern interests me: one plant compound from Paris polyphylla hitting four damage pathways instead of one, with researchers mapping exactly how it works through cGMP and PKG signaling. That mechanistic groundwork matters before anyone gets excited about a liver-protective compound. But this is mouse and cell data only, not something a person can act on yet. If you drink regularly, what actually helps today is cutting back, eating cruciferous vegetables and bitter greens, and getting enough glutathione-supporting foods like garlic, onions and eggs. I'll watch for animal safety work next.
— Dr. AxeStory summary
- Who
- Not reported (ethanol-exposed hepatocytes and a mouse model of alcoholic liver disease)
- Design
- Lab and animal study testing polyphyllin I, a compound from Paris polyphylla, in ethanol-exposed liver cells and mice
- Dose
- Not reported
- Primary result
- Polyphyllin I engaged PDE6D, raised cGMP, activated PKG, and eased ferroptosis, fat buildup, oxidative stress and inflammation in liver cells and mice
- Secondary
- Blocking PDE6D worsened ethanol-induced cell death; a PDE6D-degrading drug reproduced the protective effects; blocking PKG reversed all four protective effects
- Funding / conflicts
- Funding and conflicts not reported in the abstract.
- Date
- Oct 30, 2026